APO Research, Inc.

APO RESEARCH · REPORT

Medical Device Penetration Testing Services

Selected research

Market Outlook & Growth Opportunities

Global Medical Device Penetration Testing Services Market Outlook and Growth Opportunities 2026

Market perspective

The global Medical Device Penetration Testing Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Medical Device Penetration Testing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Medical Device Penetration Testing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Medical Device Penetration Testing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Medical Device Penetration Testing Services market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Medical Device Penetration Testing Services market include UL Solutions, TÜV SÜD, Intertek, SGS, atsec, Bureau Veritas Cybersecurity, DEKRA, BSI and MedSec, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Medical Device Penetration Testing Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Medical Device Penetration Testing Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Medical Device Penetration Testing Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Medical Device Penetration Testing Services market.

Medical Device Penetration Testing Services Segment by Company

UL Solutions

TÜV SÜD

Intertek

SGS

atsec

Bureau Veritas Cybersecurity

DEKRA

BSI

MedSec

MedCrypt

NCC Group

IOActive

Praetorian

NetSPI

Palindrome Technologies

CMD MedTech

Vumetric

Blue Goat Cyber

MedWare Cyber

Sekurno

Centre Testing International Group Co., Ltd.

Shenzhen Academy of Metrology & Quality Inspection

Medical Device Penetration Testing Services Segment by Type

Black-box Dynamic Testing

White-box Code Auditing

Medical Device Penetration Testing Services Segment by Application

Medical Device Manufacturing

In Vitro Diagnostic Equipment

Medical Institutions

Other

Medical Device Penetration Testing Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Medical Device Penetration Testing Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Medical Device Penetration Testing Services key companies, revenue, market share, and recent developments.

3. To split the Medical Device Penetration Testing Services breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Medical Device Penetration Testing Services market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Medical Device Penetration Testing Services significant trends, drivers, influence factors in global and regions.

6. To analyze Medical Device Penetration Testing Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Device Penetration Testing Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medical Device Penetration Testing Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Device Penetration Testing Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Medical Device Penetration Testing Services industry.

Chapter 3: Detailed analysis of Medical Device Penetration Testing Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Medical Device Penetration Testing Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Medical Device Penetration Testing Services in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Medical Device Penetration Testing Services Industry Trends Table 2. Medical Device Penetration Testing Services Industry Drivers Table 3. Medical Device Penetration Testing Services Industry Opportunities and Challenges Table 4. Medical Device Penetration Testing Services Industry Restraints Table 5. Global Medical Device Penetration Testing Services Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Medical Device Penetration Testing Services Revenue Share by Company (2021-2026) Table 7. Global Medical Device Penetration Testing Services Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Medical Device Penetration Testing Services Key Company Manufacturing Base & Headquarters Table 9. Global Medical Device Penetration Testing Services Company, Product Type & Application Table 10. Global Medical Device Penetration Testing Services Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Medical Device Penetration Testing Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Black-box Dynamic Testing Table 15. Significant Companies of White-box Code Auditing Table 16. Global Medical Device Penetration Testing Services Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Medical Device Penetration Testing Services Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Medical Device Penetration Testing Services Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Medical Device Penetration Testing Services Sales Value Share by Type (2021-2026) Table 20. Global Medical Device Penetration Testing Services Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Medical Device Manufacturing Table 22. Significant Companies of In Vitro Diagnostic Equipment Table 23. Significant Companies of Medical Institutions Table 24. Significant Companies of Other Table 25. Global Medical Device Penetration Testing Services Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Medical Device Penetration Testing Services Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Medical Device Penetration Testing Services Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Medical Device Penetration Testing Services Sales Value Share by Application (2021-2026) Table 29. Global Medical Device Penetration Testing Services Sales Value Share by Application (2027-2032) Table 30. Global Medical Device Penetration Testing Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Medical Device Penetration Testing Services Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Medical Device Penetration Testing Services Sales Value Share by Region (2021-2026) Table 33. Global Medical Device Penetration Testing Services Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Medical Device Penetration Testing Services Sales Value Share by Region (2027-2032) Table 35. Global Medical Device Penetration Testing Services Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Medical Device Penetration Testing Services Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Medical Device Penetration Testing Services Sales Value Market Share by Country (2021-2026) Table 38. Global Medical Device Penetration Testing Services Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Medical Device Penetration Testing Services Sales Value Market Share by Country (2027-2032) Table 40. UL Solutions Company Information Table 41. UL Solutions Business Overview Table 42. UL Solutions Medical Device Penetration Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. UL Solutions Medical Device Penetration Testing Services Product Portfolio Table 44. UL Solutions Recent Development Table 45. TÜV SÜD Company Information Table 46. TÜV SÜD Business Overview Table 47. TÜV SÜD Medical Device Penetration Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. TÜV SÜD Medical Device Penetration Testing Services Product Portfolio Table 49. TÜV SÜD Recent Development Table 50. Intertek Company Information Table 51. Intertek Business Overview Table 52. Intertek Medical Device Penetration Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Intertek Medical Device Penetration Testing Services Product Portfolio Table 54. Intertek Recent Development Table 55. SGS Company Information Table 56. SGS Business Overview Table 57. SGS Medical Device Penetration Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. SGS Medical Device Penetration Testing Services Product Portfolio Table 59. SGS Recent Development Table 60. atsec Company Information Table 61. atsec Business Overview Table 62. atsec Medical Device Penetration Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. atsec Medical Device Penetration Testing Services Product Portfolio Table 64. atsec Recent Development Table 65. Bureau Veritas Cybersecurity Company Information Table 66. Bureau Veritas Cybersecurity Business Overview Table 67. Bureau Veritas Cybersecurity Medical Device Penetration Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Bureau Veritas Cybersecurity Medical Device Penetration Testing Services Product Portfolio Table 69. Bureau Veritas Cybersecurity Recent Development Table 70. DEKRA Company Information Table 71. DEKRA Business Overview Table 72. DEKRA Medical Device Penetration Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. DEKRA Medical Device Penetration Testing Services Product Portfolio Table 74. DEKRA Recent Development Table 75. BSI Company Information Table 76. BSI Business Overview Table 77. BSI Medical Device Penetration Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. BSI Medical Device Penetration Testing Services Product Portfolio Table 79. BSI Recent Development Table 80. MedSec Company Information Table 81. MedSec Business Overview Table 82. MedSec Medical Device Penetration Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. MedSec Medical Device Penetration Testing Services Product Portfolio Table 84. MedSec Recent Development Table 85. MedCrypt Company Information Table 86. MedCrypt Business Overview Table 87. MedCrypt Medical Device Penetration Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. MedCrypt Medical Device Penetration Testing Services Product Portfolio Table 89. MedCrypt Recent Development Table 90. NCC Group Company Information Table 91. NCC Group Business Overview Table 92. NCC Group Medical Device Penetration Testing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. NCC Group Medical Device Penetration Testing Services Product Portfolio Table 94. NCC Group Recent Development Table 95. IOActive Company Information Table 96. IOActive Business Overview Table 97. IOActive Medical Device Penetration Testing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. IOActive Medical Device Penetration Testing Services Product Portfolio Table 99. IOActive Recent Development Table 100. Praetorian Company Information Table 101. Praetorian Business Overview Table 102. Praetorian Medical Device Penetration Testing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Praetorian Medical Device Penetration Testing Services Product Portfolio Table 104. Praetorian Recent Development Table 105. NetSPI Company Information Table 106. NetSPI Business Overview Table 107. NetSPI Medical Device Penetration Testing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. NetSPI Medical Device Penetration Testing Services Product Portfolio Table 109. NetSPI Recent Development Table 110. Palindrome Technologies Company Information Table 111. Palindrome Technologies Business Overview Table 112. Palindrome Technologies Medical Device Penetration Testing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Palindrome Technologies Medical Device Penetration Testing Services Product Portfolio Table 114. Palindrome Technologies Recent Development Table 115. CMD MedTech Company Information Table 116. CMD MedTech Business Overview Table 117. CMD MedTech Medical Device Penetration Testing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. CMD MedTech Medical Device Penetration Testing Services Product Portfolio Table 119. CMD MedTech Recent Development Table 120. Vumetric Company Information Table 121. Vumetric Business Overview Table 122. Vumetric Medical Device Penetration Testing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. Vumetric Medical Device Penetration Testing Services Product Portfolio Table 124. Vumetric Recent Development Table 125. Blue Goat Cyber Company Information Table 126. Blue Goat Cyber Business Overview Table 127. Blue Goat Cyber Medical Device Penetration Testing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 128. Blue Goat Cyber Medical Device Penetration Testing Services Product Portfolio Table 129. Blue Goat Cyber Recent Development Table 130. MedWare Cyber Company Information Table 131. MedWare Cyber Business Overview Table 132. MedWare Cyber Medical Device Penetration Testing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 133. MedWare Cyber Medical Device Penetration Testing Services Product Portfolio Table 134. MedWare Cyber Recent Development Table 135. Sekurno Company Information Table 136. Sekurno Business Overview Table 137. Sekurno Medical Device Penetration Testing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 138. Sekurno Medical Device Penetration Testing Services Product Portfolio Table 139. Sekurno Recent Development Table 140. Centre Testing International Group Co., Ltd. Company Information Table 141. Centre Testing International Group Co., Ltd. Business Overview Table 142. Centre Testing International Group Co., Ltd. Medical Device Penetration Testing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 143. Centre Testing International Group Co., Ltd. Medical Device Penetration Testing Services Product Portfolio Table 144. Centre Testing International Group Co., Ltd. Recent Development Table 145. Shenzhen Academy of Metrology & Quality Inspection Company Information Table 146. Shenzhen Academy of Metrology & Quality Inspection Business Overview Table 147. Shenzhen Academy of Metrology & Quality Inspection Medical Device Penetration Testing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 148. Shenzhen Academy of Metrology & Quality Inspection Medical Device Penetration Testing Services Product Portfolio Table 149. Shenzhen Academy of Metrology & Quality Inspection Recent Development Table 150. Research Programs/Design for This Report Table 151. Authors List of This Report Table 152. Secondary Sources Table 153. Primary Sources List of Figures Figure 1. Medical Device Penetration Testing Services Product Image Figure 2. Global Medical Device Penetration Testing Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Medical Device Penetration Testing Services Market Size (2021-2032) & (US$ Million) Figure 4. Global Medical Device Penetration Testing Services Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Black-box Dynamic Testing Image Figure 8. White-box Code Auditing Image Figure 9. Global Medical Device Penetration Testing Services Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Medical Device Penetration Testing Services Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Medical Device Penetration Testing Services Sales Value Share by Type (2021-2032) Figure 12. Medical Device Manufacturing Image Figure 13. In Vitro Diagnostic Equipment Image Figure 14. Medical Institutions Image Figure 15. Other Image Figure 16. Global Medical Device Penetration Testing Services Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Medical Device Penetration Testing Services Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Medical Device Penetration Testing Services Sales Value Share by Application (2021-2032) Figure 19. Global Medical Device Penetration Testing Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Medical Device Penetration Testing Services Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Medical Device Penetration Testing Services Sales Value (2021-2032) & (US$ Million) Figure 22. North America Medical Device Penetration Testing Services Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Medical Device Penetration Testing Services Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Medical Device Penetration Testing Services Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Medical Device Penetration Testing Services Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Medical Device Penetration Testing Services Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Medical Device Penetration Testing Services Sales Value (2021-2032) & (US$ Million) Figure 28. South America Medical Device Penetration Testing Services Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Medical Device Penetration Testing Services Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Medical Device Penetration Testing Services Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Black-box Dynamic Testing
  • White-box Code Auditing
Applications
  • Medical Device Manufacturing
  • In Vitro Diagnostic Equipment
  • Medical Institutions
  • Other
Companies covered
  • UL Solutions
  • TÜV SÜD
  • Intertek
  • SGS
  • atsec
  • Bureau Veritas Cybersecurity
  • DEKRA
  • BSI
  • MedSec
  • MedCrypt
  • NCC Group
  • IOActive
  • Praetorian
  • NetSPI
  • Palindrome Technologies
  • CMD MedTech
  • Vumetric
  • Blue Goat Cyber
  • MedWare Cyber
  • Sekurno
  • Centre Testing International Group Co., Ltd.
  • Shenzhen Academy of Metrology & Quality Inspection

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Medical Device Penetration Testing Services Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Medical Device Penetration Testing Services Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Medical Device Penetration Testing Services Market Dynamics
  1. 2.1 Medical Device Penetration Testing Services Industry Trends
  2. 2.2 Medical Device Penetration Testing Services Industry Drivers
  3. 2.3 Medical Device Penetration Testing Services Industry Opportunities and Challenges
  4. 2.4 Medical Device Penetration Testing Services Industry Restraints
3 Medical Device Penetration Testing Services Market by Company
  1. 3.1 Global Medical Device Penetration Testing Services Company Revenue Ranking in 2025
  2. 3.2 Global Medical Device Penetration Testing Services Revenue by Company (2021-2026)
  3. 3.3 Global Medical Device Penetration Testing Services Company Ranking (2024-2026)
  4. 3.4 Global Medical Device Penetration Testing Services Company Manufacturing Base and Headquarters
  5. 3.5 Global Medical Device Penetration Testing Services Company Product Type and Application
  6. 3.6 Global Medical Device Penetration Testing Services Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Medical Device Penetration Testing Services Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Medical Device Penetration Testing Services Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Medical Device Penetration Testing Services Market by Type
  1. 4.1 Medical Device Penetration Testing Services Type Introduction
  2. 4.1.1 Black-box Dynamic Testing
  3. 4.1.2 White-box Code Auditing
  4. 4.2 Global Medical Device Penetration Testing Services Sales Value by Type
  5. 4.2.1 Global Medical Device Penetration Testing Services Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Medical Device Penetration Testing Services Sales Value by Type (2021-2032)
  7. 4.2.3 Global Medical Device Penetration Testing Services Sales Value Share by Type (2021-2032)
5 Medical Device Penetration Testing Services Market by Application
  1. 5.1 Medical Device Penetration Testing Services Application Introduction
  2. 5.1.1 Medical Device Manufacturing
  3. 5.1.2 In Vitro Diagnostic Equipment
  4. 5.1.3 Medical Institutions
  5. 5.1.4 Other
  6. 5.2 Global Medical Device Penetration Testing Services Sales Value by Application
  7. 5.2.1 Global Medical Device Penetration Testing Services Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Medical Device Penetration Testing Services Sales Value by Application (2021-2032)
  9. 5.2.3 Global Medical Device Penetration Testing Services Sales Value Share by Application (2021-2032)
6 Medical Device Penetration Testing Services Regional Value Analysis
  1. 6.1 Global Medical Device Penetration Testing Services Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Medical Device Penetration Testing Services Sales Value by Region (2021-2032)
  3. 6.2.1 Global Medical Device Penetration Testing Services Sales Value by Region: 2021-2026
  4. 6.2.2 Global Medical Device Penetration Testing Services Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Medical Device Penetration Testing Services Sales Value (2021-2032)
  7. 6.3.2 North America Medical Device Penetration Testing Services Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Medical Device Penetration Testing Services Sales Value (2021-2032)
  10. 6.4.2 Europe Medical Device Penetration Testing Services Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Medical Device Penetration Testing Services Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Medical Device Penetration Testing Services Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Medical Device Penetration Testing Services Sales Value (2021-2032)
  16. 6.6.2 South America Medical Device Penetration Testing Services Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Medical Device Penetration Testing Services Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Medical Device Penetration Testing Services Sales Value Share by Country, 2025 VS 2032
7 Medical Device Penetration Testing Services Country-level Value Analysis
  1. 7.1 Global Medical Device Penetration Testing Services Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Medical Device Penetration Testing Services Sales Value by Country (2021-2032)
  3. 7.2.1 Global Medical Device Penetration Testing Services Sales Value by Country (2021-2026)
  4. 7.2.2 Global Medical Device Penetration Testing Services Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 UL Solutions
  2. 8.1.1 UL Solutions Company Information
  3. 8.1.2 UL Solutions Business Overview
  4. 8.1.3 UL Solutions Medical Device Penetration Testing Services Revenue and Gross Margin (2021-2026)
  5. 8.1.4 UL Solutions Medical Device Penetration Testing Services Product Portfolio
  6. 8.1.5 UL Solutions Recent Developments
  7. 8.2 TÜV SÜD
  8. 8.2.1 TÜV SÜD Company Information
  9. 8.2.2 TÜV SÜD Business Overview
  10. 8.2.3 TÜV SÜD Medical Device Penetration Testing Services Revenue and Gross Margin (2021-2026)
  11. 8.2.4 TÜV SÜD Medical Device Penetration Testing Services Product Portfolio
  12. 8.2.5 TÜV SÜD Recent Developments
  13. 8.3 Intertek
  14. 8.3.1 Intertek Company Information
  15. 8.3.2 Intertek Business Overview
  16. 8.3.3 Intertek Medical Device Penetration Testing Services Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Intertek Medical Device Penetration Testing Services Product Portfolio
  18. 8.3.5 Intertek Recent Developments
  19. 8.4 SGS
  20. 8.4.1 SGS Company Information
  21. 8.4.2 SGS Business Overview
  22. 8.4.3 SGS Medical Device Penetration Testing Services Revenue and Gross Margin (2021-2026)
  23. 8.4.4 SGS Medical Device Penetration Testing Services Product Portfolio
  24. 8.4.5 SGS Recent Developments
  25. 8.5 atsec
  26. 8.5.1 atsec Company Information
  27. 8.5.2 atsec Business Overview
  28. 8.5.3 atsec Medical Device Penetration Testing Services Revenue and Gross Margin (2021-2026)
  29. 8.5.4 atsec Medical Device Penetration Testing Services Product Portfolio
  30. 8.5.5 atsec Recent Developments
  31. 8.6 Bureau Veritas Cybersecurity
  32. 8.6.1 Bureau Veritas Cybersecurity Company Information
  33. 8.6.2 Bureau Veritas Cybersecurity Business Overview
  34. 8.6.3 Bureau Veritas Cybersecurity Medical Device Penetration Testing Services Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Bureau Veritas Cybersecurity Medical Device Penetration Testing Services Product Portfolio
  36. 8.6.5 Bureau Veritas Cybersecurity Recent Developments
  37. 8.7 DEKRA
  38. 8.7.1 DEKRA Company Information
  39. 8.7.2 DEKRA Business Overview
  40. 8.7.3 DEKRA Medical Device Penetration Testing Services Revenue and Gross Margin (2021-2026)
  41. 8.7.4 DEKRA Medical Device Penetration Testing Services Product Portfolio
  42. 8.7.5 DEKRA Recent Developments
  43. 8.8 BSI
  44. 8.8.1 BSI Company Information
  45. 8.8.2 BSI Business Overview
  46. 8.8.3 BSI Medical Device Penetration Testing Services Revenue and Gross Margin (2021-2026)
  47. 8.8.4 BSI Medical Device Penetration Testing Services Product Portfolio
  48. 8.8.5 BSI Recent Developments
  49. 8.9 MedSec
  50. 8.9.1 MedSec Company Information
  51. 8.9.2 MedSec Business Overview
  52. 8.9.3 MedSec Medical Device Penetration Testing Services Revenue and Gross Margin (2021-2026)
  53. 8.9.4 MedSec Medical Device Penetration Testing Services Product Portfolio
  54. 8.9.5 MedSec Recent Developments
  55. 8.10 MedCrypt
  56. 8.10.1 MedCrypt Company Information
  57. 8.10.2 MedCrypt Business Overview
  58. 8.10.3 MedCrypt Medical Device Penetration Testing Services Revenue and Gross Margin (2021-2026)
  59. 8.10.4 MedCrypt Medical Device Penetration Testing Services Product Portfolio
  60. 8.10.5 MedCrypt Recent Developments
  61. 8.11 NCC Group
  62. 8.11.1 NCC Group Company Information
  63. 8.11.2 NCC Group Business Overview
  64. 8.11.3 NCC Group Medical Device Penetration Testing Services Revenue and Gross Margin (2021-2026)
  65. 8.11.4 NCC Group Medical Device Penetration Testing Services Product Portfolio
  66. 8.11.5 NCC Group Recent Developments
  67. 8.12 IOActive
  68. 8.12.1 IOActive Company Information
  69. 8.12.2 IOActive Business Overview
  70. 8.12.3 IOActive Medical Device Penetration Testing Services Revenue and Gross Margin (2021-2026)
  71. 8.12.4 IOActive Medical Device Penetration Testing Services Product Portfolio
  72. 8.12.5 IOActive Recent Developments
  73. 8.13 Praetorian
  74. 8.13.1 Praetorian Company Information
  75. 8.13.2 Praetorian Business Overview
  76. 8.13.3 Praetorian Medical Device Penetration Testing Services Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Praetorian Medical Device Penetration Testing Services Product Portfolio
  78. 8.13.5 Praetorian Recent Developments
  79. 8.14 NetSPI
  80. 8.14.1 NetSPI Company Information
  81. 8.14.2 NetSPI Business Overview
  82. 8.14.3 NetSPI Medical Device Penetration Testing Services Revenue and Gross Margin (2021-2026)
  83. 8.14.4 NetSPI Medical Device Penetration Testing Services Product Portfolio
  84. 8.14.5 NetSPI Recent Developments
  85. 8.15 Palindrome Technologies
  86. 8.15.1 Palindrome Technologies Company Information
  87. 8.15.2 Palindrome Technologies Business Overview
  88. 8.15.3 Palindrome Technologies Medical Device Penetration Testing Services Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Palindrome Technologies Medical Device Penetration Testing Services Product Portfolio
  90. 8.15.5 Palindrome Technologies Recent Developments
  91. 8.16 CMD MedTech
  92. 8.16.1 CMD MedTech Company Information
  93. 8.16.2 CMD MedTech Business Overview
  94. 8.16.3 CMD MedTech Medical Device Penetration Testing Services Revenue and Gross Margin (2021-2026)
  95. 8.16.4 CMD MedTech Medical Device Penetration Testing Services Product Portfolio
  96. 8.16.5 CMD MedTech Recent Developments
  97. 8.17 Vumetric
  98. 8.17.1 Vumetric Company Information
  99. 8.17.2 Vumetric Business Overview
  100. 8.17.3 Vumetric Medical Device Penetration Testing Services Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Vumetric Medical Device Penetration Testing Services Product Portfolio
  102. 8.17.5 Vumetric Recent Developments
  103. 8.18 Blue Goat Cyber
  104. 8.18.1 Blue Goat Cyber Company Information
  105. 8.18.2 Blue Goat Cyber Business Overview
  106. 8.18.3 Blue Goat Cyber Medical Device Penetration Testing Services Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Blue Goat Cyber Medical Device Penetration Testing Services Product Portfolio
  108. 8.18.5 Blue Goat Cyber Recent Developments
  109. 8.19 MedWare Cyber
  110. 8.19.1 MedWare Cyber Company Information
  111. 8.19.2 MedWare Cyber Business Overview
  112. 8.19.3 MedWare Cyber Medical Device Penetration Testing Services Revenue and Gross Margin (2021-2026)
  113. 8.19.4 MedWare Cyber Medical Device Penetration Testing Services Product Portfolio
  114. 8.19.5 MedWare Cyber Recent Developments
  115. 8.20 Sekurno
  116. 8.20.1 Sekurno Company Information
  117. 8.20.2 Sekurno Business Overview
  118. 8.20.3 Sekurno Medical Device Penetration Testing Services Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Sekurno Medical Device Penetration Testing Services Product Portfolio
  120. 8.20.5 Sekurno Recent Developments
  121. 8.21 Centre Testing International Group Co., Ltd.
  122. 8.21.1 Centre Testing International Group Co., Ltd. Company Information
  123. 8.21.2 Centre Testing International Group Co., Ltd. Business Overview
  124. 8.21.3 Centre Testing International Group Co., Ltd. Medical Device Penetration Testing Services Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Centre Testing International Group Co., Ltd. Medical Device Penetration Testing Services Product Portfolio
  126. 8.21.5 Centre Testing International Group Co., Ltd. Recent Developments
  127. 8.22 Shenzhen Academy of Metrology & Quality Inspection
  128. 8.22.1 Shenzhen Academy of Metrology & Quality Inspection Company Information
  129. 8.22.2 Shenzhen Academy of Metrology & Quality Inspection Business Overview
  130. 8.22.3 Shenzhen Academy of Metrology & Quality Inspection Medical Device Penetration Testing Services Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Shenzhen Academy of Metrology & Quality Inspection Medical Device Penetration Testing Services Product Portfolio
  132. 8.22.5 Shenzhen Academy of Metrology & Quality Inspection Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.